Brief: CureVac: Start Of Combined Phase 1/2 Study In Avian Influenza
24/04/2024 12:05
April 24 (Reuters) - CUREVAC NV 5CV.DE :
* ANNOUNCES START OF COMBINED PHASE 1/2 STUDY IN AVIAN
INFLUENZA
(H5N1); DEVELOPMENT IN COLLABORATION WITH GSK
Source text for Eikon: ID:nEQ3RgRjGa
Further company coverage: 5CV.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028